About ImpriMed
ImpriMed is a company based in Palo Alto (United States) founded in 2017 by Jamin Koo, Hye Ryeon Lee, and Sungwon Lim. ImpriMed has raised $44.92 million across 6 funding rounds from investors including SK Telecom, Korean Development Bank and Plug and Play Tech Center. ImpriMed operates in a competitive market with competitors including VetDC, Animal Life Sciences, CanFel Therapeutics, Vetco Pharmaceuticals and Blue Horizon Biotech, among others.
- Total Equity Funding$44.92M (USD)
in 6 rounds
- Latest Funding Round$10M (USD), Series A
Sep 2026
- InvestorsSK Telecom
& 20 more
Apps and channels of ImpriMed
its YouTube channel ImpriMed has 269 subscribers and 30 videos.
Videos from ImpriMed
The most watched videos on ImpriMed's YouTube channel, ImpriMed (269 subscribers). Click a video to play it here.
More on ImpriMed.
Funding Insights of ImpriMed
ImpriMed has successfully raised a total of $44.92M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $10 million completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $44.92M
- Total Rounds 6
- Last Round Series A — $10M
- Investors Count 21
All 6 funding rounds of ImpriMed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2026 | $10M | Series A | – | – | |
| Nov 2023 | $23.22M | Series A | – | SK Telecom, SBVA | |
| Apr 2021 | $300,000 | Grant | – | – | – |
| Apr 2021 | $7.7M | Seed | – | HGI | |
| Apr 2019 | $4M | Seed | – | Draper Associates, Plug and Play Tech Center | |
| Jun 2018 | – | Seed | – | BASS Investment | – |
21 investors in total: 21 institutional.
Investors in ImpriMed
ImpriMed has secured backing from 21 investors, including institutional and venture fund investors. Prominent investors backing the company include SK Telecom, Korean Development Bank and Plug and Play Tech Center.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Ignite Innovation is focused on empowering early-stage founders. | – | igniteinnovation.com | - | |
VC firm for seed to growth-stage firms | – | murexpartners.com | Seoul, South Korea | |
Venture capital investments are made in early-stage innovative companies. | – | hrz.vc | - | |
Early-stage venture capital arm of SoftBank Group | – | sbvacorp.com | Seoul, South Korea | |
Early-stage technology companies receive venture capital investments. | – | draper.vc | San Mateo, United States | |
Startups are accelerated and invested in across multiple tech sectors. | 2006 | plugandplaytechcenter.com | Sunnyvale, United States | |
Startups are accelerated by Stanford-backed program in Palo Alto. | – | startx.com | Palo Alto, United States | |
BASS Ventures is engaged in empowering visionary founders through investments. | – | bass.vc | - | |
Early-stage centric VC firm funding companies in the US and China | – | draperdragon.com | Shanghai, China | |
Investments are made by BonAngels in early-stage Asian tech companies. | – | bonangels.net | Seoul, South Korea |
Investor details for ImpriMed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ImpriMed
26 people are tracked at ImpriMed (5 in leadership, 8 in board & advisors, 13 in team).
| Name | Role | Group |
|---|---|---|
Jamin Koo | Co-Founder & CTO | Leadership |
Hye Ryeon Lee | Co-Founder | Leadership |
Sungwon Lim | Co-Founder & CEO | Leadership |
Ilona Holcomb | Director, Bioscience | Leadership |
Mary Ocnean | VP, Commercial Operations | Leadership |
Kevin Choy | Medical Consultant | Board & advisors |
Carlos Bustamante | Advisor | Board & advisors |
Wendi Velando Rankin | Advisor | Board & advisors |
Jinjoo Kim | Director | Board & advisors |
Tariq Shah | Business Consultant | Board & advisors |
Sean McDonald | Board | Board & advisors |
Douglas H. Thamm | Advisor | Board & advisors |
Robert Barthel | Veterinary Science Consultant | Board & advisors |
Collin H. Cavanaugh | Senior Sales Manager | Team |
Jerry Cromarty | Laboratory Technician | Team |
Hojin Nam | Senior Software Engineer & Manager | Team |
Heeju Choi | Software Engineer | Team |
Stanley Park | Business Operations Manager | Team |
Murad Durrani | Software Engineer | Team |
Minh Bui | Business Operations Associate | Team |
6 more people are available in the full profile.
Complete people profiles for ImpriMed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ImpriMed
3 dated milestones of ImpriMed across 9 years, from founding to its latest funding, stage changes and deals.
- Founded ImpriMed is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $10.0M.
Competitors of ImpriMed
ImpriMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as VetDC, Animal Life Sciences, CanFel Therapeutics, Vetco Pharmaceuticals and Blue Horizon Biotech, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vet-dc.com | 2010 | Fort Collins, United States | $5.49M | – | Anticancer therapies for animals are developed by VetDC. | |
| animallifesciences.com | 2018 | New York, United States | $198,800 | – | Developer of pet food, supplements and therapeutics to treat cancer in animals | |
| canfeltherapeutics.com | 1999 | Torrance, United States | – | – | Cancer therapeutics for animals are developed using innovative platforms. | |
| vetcogroup.com | 2012 | Sanchong, Taiwan | – | – | Offers comprehensive pharmaceutical products for treating cancer in animals. | |
| bluehorizonbiotech.com | 2020 | United States | – | – | Develops innovative veterinary therapeutics for cancer treatment. |
Detailed competitors of ImpriMed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ImpriMed
The website of ImpriMed (imprimedicine.com) receives about 59.4K visits a month and ranks #586,031 among all websites worldwide, #4,755 in Pet Food and Supplies.
- Monthly visits59.4K
▼ 10.1% vs previous month
- Unique visitors33.8K
per month
- Global rank#586,031
among all websites
- Category rank#4,755
Pets and Animals · Pet Food and Supplies
- Bounce rate65%
- Pages per visit1.5
- Average visit55 sec
- DevicesDesktop 30% · Mobile 70%
Websites whose visitors overlap most with ImpriMed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
morrisanimalfoundation.org | morrisanimalfoundation.org | 100% | – | #682,186 | – |
wearethecure.org | wearethecure.org | 97% | – | #691,469 | – |
acfoundation.org | acfoundation.org | 96% | – | #1,915,021 | – |
nahf.org | nahf.org | 95% | – | #1,675,863 | – |
dogcancer.com | dogcancer.com | 95% | – | #826,425 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for ImpriMed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Imprimed
Complete news archive for ImpriMed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to ImpriMed
10 companies that operate in the same segment as ImpriMed (Veterinary Digital Health), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Practice and prescription management software is provided for veterinary professionals. | 2010 | Portland, Oregon, United States | USD 291.64 M | – | – | |
Animal medicines, vaccines, and diagnostics are manufactured and supplied. | 2012 | Brussels, Brussels-capital Region, Belgium | – | – | – | |
Veterinary pharmacy services are delivered by VetSource to practices. | 2005 | Portland, Oregon, United States | USD 81.25 M | – | – | |
Animal health therapeutics are developed and supplied globally by Ceva. | 1999 | Libourne, Nouvelle-aquitaine, France | USD 214.35 M | – | – | |
Digital platform for pet insurance | 2020 | Stockholm, Sweden | USD 114.08 M | – | – | |
App based platform providing veterinary services and clinical management solutions for veterinarians | 2018 | Beverly Hills, California, United States | USD 58.81 M | – | – | |
Online client communication platform for veterinary doctors | 2013 | San Diego, California, United States | USD 14.11 M | USD 14.38 M | 1 | |
Virtual veterinary care is provided via an app platform. | 2018 | Los Angeles, California, United States | USD 210 M | – | 163 | |
Comprehensive customer engagement platform for veterinary clinics is provided. | 2015 | Austin, Texas, United States | USD 50.3 M | – | – | |
Veterinary appointments are booked via an online platform. | 2017 | Brooklyn, New York, United States | USD 243 M | – | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ImpriMed
ImpriMed was founded in 2017 and raised its 1st funding round 1 year after it was founded.
ImpriMed is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Sungwon Lim is the current CEO of ImpriMed. They have also founded this company.
ImpriMed is a funded company, having raised a total of $44.92M across 6 funding rounds to date.
ImpriMed was founded in 2017 and is headquartered in Palo Alto, United States. The company operates in the veterinary oncology sector, focusing on precision medicine. Biopsies of live cancer cells from pets are conducted to evaluate drug responses prior to treatment. Data-driven technology is then applied to support veterinary oncologists in creating individualized medicinal regimens tailored to specific patient needs.
ImpriMed's top competitors include VetDC, Animal Life Sciences and CanFel Therapeutics.
ImpriMed has 21 investors. Key investors include SK Telecom, Korean Development Bank, Plug and Play Tech Center, Murex, and Byucksan.
ImpriMed operates through Imprimed, Inc..